Browse > Article
http://dx.doi.org/10.5620/eht.e2014018

The separation of arsenic metabolites in urine by high performance liquid chromatography-inductively coupled plasma-mass spectrometry  

Chung, Jin-Yong (Heavy Metal Exposure Environmental Health Center, Dong-A University)
Lim, Hyoun-Ju (Heavy Metal Exposure Environmental Health Center, Dong-A University)
Kim, Young-Jin (Agilent Technologies Korea Ltd.)
Song, Ki-Hoon (Department of Dermatology, Dong-A University Hospital)
Kim, Byoung-Gwon (Heavy Metal Exposure Environmental Health Center, Dong-A University)
Hong, Young-Seoub (Heavy Metal Exposure Environmental Health Center, Dong-A University)
Publication Information
Environmental Analysis Health and Toxicology / v.29, no., 2014 , pp. 18.1-18.9 More about this Journal
Abstract
Objectives The purpose of this study was to determine a separation method for each arsenic metabolite in urine by using a high performance liquid chromatography (HPLC)-inductively coupled plasma-mass spectrometer (ICP-MS). Methods Separation of the arsenic metabolites was conducted in urine by using a polymeric anion-exchange (Hamilton PRP X-100, $4.6mm{\times}150mm$, $5{\mu}m$) column on Agilent Technologies 1260 Infinity LC system coupled to Agilent Technologies 7700 series ICP/MS equipment using argon as the plasma gas. Results All five important arsenic metabolites in urine were separated within 16 minutes in the order of arsenobetaine, arsenite, dimethylarsinate, monomethylarsonate and arsenate with detection limits ranging from 0.15 to $0.27{\mu}g/L$ ($40{\mu}L$ injection). We used G-EQUAS No. 52, the German external quality assessment scheme and standard reference material 2669, National Institute of Standard and Technology, to validate our analyses. Conclusions The method for separation of arsenic metabolites in urine was established by using HPLC-ICP-MS. This method contributes to the evaluation of arsenic exposure, health effect assessment and other bio-monitoring studies for arsenic exposure in South Korea.
Keywords
Arsenic; Arsenic metabolites; HPLC-ICP-MS; Urine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chen LW, Lu X, Le XC. Complementary chromatography separation combined with hydride generation-inductively coupled plasma mass spectrometry for arsenic speciation in human urine. Anal Chim Acta 2010;675(1):71-75.   DOI
2 Buchet JP, Lauwerys R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 1981;48(1):71-79.   DOI
3 Coelho NM, Coelho LM, Lima ES, Pastor A, Guardia Mde L. Determination of arsenic compounds in beverages by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Talanta 2005;66(4):818-822.   DOI
4 Roig-Navarro AF, Martinez-Bravo Y, Lopez FJ, Hernández F. Simultaneous determination of arsenic species and chromium (VI) by high-performance liquid chromatography-inductively coupled plasma-mass spectrometry. J Chromatogr A 2001;912(2):319-327.   DOI
5 Gibb H, Haver C, Gaylor D, Ramasamy S, Lee JS, Lobdell D, et al. Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic. Environ Health Perspect 2011;119(3):284-290.
6 Rossman TG, Uddin AN, Burns FJ. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 2004; 198(3):394-404.   DOI
7 Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, et al. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 2010;376(9737):252-258.   DOI   ScienceOn
8 International Agency for Research on Cancer. Arsenic and arsenic compounds [cited 2014 Aug 14]. Available from: http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-6.pdf.
9 Ferreccio C, González C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 2000;11(6):673-679.   DOI   ScienceOn
10 Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U, Dear K, et al. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005;16(1):82-86.   DOI   ScienceOn
11 Lee MY, Bae ON, Chung SM, Kang KT, Lee JY, Chung JH. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol Appl Pharmacol 2002;179(2):83-88.   DOI   ScienceOn
12 Bodwell JE, Kingsley LA, Hamilton JW. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem Res Toxicol 2004;17(8):1064-1076.   DOI
13 Tseng CH, Tai TY, Chong CK, Tseng CP, Lai MS, Lin BJ, et al. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 2000;108(9):847-851.   DOI
14 Drobna Z, Walton FS, Paul DS, Xing W, Thomas DJ, Styblo M. Metabolism of arsenic in human liver: the role of membrane transporters. Arch Toxicol 2010;84(1):3-16.   DOI
15 Hakala E, Pyy L. Assessment of exposure to inorganic arsenic by determining the arsenic species excreted in urine. Toxicol Lett 1995;77(1-3):249-258.   DOI
16 Hindmarsh JT, McCurdy RF. Clinical and environmental aspects of arsenic toxicity. Crit Rev Clin Lab Sci 1986;23(4):315-347.   DOI
17 Ma M, Le XC. Effect of arsenosugar ingestion on urinary arsenic speciation. Clin Chem 1998;44(3):539-550.
18 Lee SK, Yoo YC, Kwon TJ, Ko YC, Yang JY, Lee SY, et al. Distribution of arsenic in Korean human tissue. Cheongju: National Toxicological Program; 2002, p. 467-478 (Korean).
19 Byun K, Won YL, Hwang YI, Koh DH, Im H, Kim EA. Assessment of arsenic exposure by measurement of urinary speciated inorganic arsenic metabolites in workers in a semiconductor manufacturing plant. Ann Occup Environ Med 2013;25(1):21.   DOI
20 Valentine JL, Kang HK, Spivey G. Arsenic levels in human blood, urine, and hair in response to exposure via drinking water. Environ Res 1979;20(1):24-32.   DOI   ScienceOn
21 Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health 1981;48(2): 111-118.   DOI
22 Le XC, Cullen WR, Reimer KJ. Human urinary arsenic excretion after one-time ingestion of seaweed, crab, and shrimp. Clin Chem 1994;40(4):617-624.
23 Mandal BK, Suzuki KT. Arsenic round the world: a review. Talanta 2002;58(1):201-235.   DOI   ScienceOn
24 Komorowicz I, Baralkiewicz D. Arsenic and its speciation in water samples by high performance liquid chromatography inductively coupled plasma mass spectrometry--last decade review. Talanta 2011;84(2):247-261.   DOI
25 Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994;139(5):484-492.
26 Tsai SM, Wang TN, Ko YC. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health 1999;54(3):186-193.   DOI